Recently, Drosophila transgenic RNAi Smn hypomorphs have been generated that display NMJ defects in an Smn dose-dependent manner (Chang et al., 2008; Sen et al., 2013), mirroring the SMN2 dosage dependence observed in SMA patients. This evidence concerns the gene SMN2 and proximal spinal muscular atrophy.